ストックスクリーナーアプリを入手
41.45
2.62%
1.06
前日終値:
$40.39
開ける：
$40.39
24時間の取引高:
830.86K
Relative Volume:
1.07
時価総額：
$1.78B
収益：
$4.85M
当期純損益:
$-114.75M
株価収益率:
-12.75
EPS:
-3.25
ネットキャッシュフロー:
$-100.36M
1週間 パフォーマンス:
+1.47%
1か月 パフォーマンス:
+18.33%
6か月 パフォーマンス:
+121.07%
1年 パフォーマンス:
+104.49%
1日の値動き範囲:
$39.82
$42.56
1週間の範囲:
$39.73
$43.67
52週間の値動き範囲:
$13.37
$43.67
Dianthus Therapeutics Inc Stock (DNTH) Company Profile
DNTH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DNTH
Dianthus Therapeutics Inc
|
41.45 | 1.73B | 4.85M | -114.75M | -100.36M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-14 | 開始されました | Truist | Buy |
| 2025-07-02 | 開始されました | William Blair | Outperform |
| 2024-12-20 | 開始されました | TD Cowen | Buy |
| 2024-10-03 | 開始されました | Oppenheimer | Outperform |
| 2024-07-26 | 開始されました | Robert W. Baird | Outperform |
| 2024-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-05-16 | 開始されました | H.C. Wainwright | Buy |
| 2024-02-15 | 開始されました | Stifel | Buy |
| 2023-12-26 | 開始されました | Jefferies | Buy |
| 2023-11-22 | 開始されました | Wedbush | Outperform |
| 2023-10-30 | 開始されました | Guggenheim | Buy |
| 2023-09-28 | 開始されました | Raymond James | Outperform |
| 2022-08-25 | ダウングレード | Goldman | Buy → Neutral |
| 2022-01-06 | アップグレード | Goldman | Neutral → Buy |
| 2021-08-20 | 再開されました | Goldman | Neutral |
| 2021-08-03 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-22 | 繰り返されました | B. Riley Securities | Buy |
| 2021-06-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-18 | 開始されました | B. Riley Securities | Buy |
| 2021-01-07 | 開始されました | Mizuho | Buy |
| 2020-06-08 | アップグレード | Goldman | Neutral → Buy |
| 2019-03-25 | ダウングレード | Goldman | Buy → Neutral |
| 2019-03-15 | 開始されました | Raymond James | Outperform |
すべてを表示
Dianthus Therapeutics Inc (DNTH) 最新ニュース
Wedbush Maintains Dianthus Therapeutics (DNTH) Outperform Recommendation - MSN
Can Dianthus Therapeutics Inc. (87E) stock deliver double digit returnsMarket Growth Report & Free Long-Term Investment Growth Plans - newser.com
How forex fluctuations impact Dianthus Therapeutics Inc. (87E) stockPortfolio Gains Summary & Safe Capital Growth Trade Ideas - newser.com
Why Dianthus Therapeutics Inc. stock remains resilient2025 Short Interest & Real-Time Volume Triggers - newser.com
How Dianthus Therapeutics Inc. (87E) stock performs in easing cyclesCEO Change & Daily Entry Point Alerts - newser.com
How Dianthus Therapeutics Inc. stock reacts to global recession fearsJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com
Views of Wall Street’s Leading Experts on Dianthus Therapeutics Inc - Setenews
Smart tools for monitoring Dianthus Therapeutics Inc.’s price action2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
What analysts say about Dianthus Therapeutics Inc 87E stock - earlytimes.in
How to escape a deep drawdown in Dianthus Therapeutics Inc.Earnings Overview Summary & AI Powered Buy/Sell Recommendations - newser.com
Candriam S.C.A. Has $4.48 Million Holdings in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Dianthus Therapeutics Insider Sold Shares Worth $7,379,887, According to a Recent SEC Filing - MarketScreener
Dianthus Therapeutics (NASDAQ:DNTH) Hits New 12-Month High – Here’s Why - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) EVP Simrat Randhawa Sells 109,031 Shares - MarketBeat
Insider Selling: Dianthus Therapeutics (NASDAQ:DNTH) EVP Sells 87,507 Shares of Stock - MarketBeat
What dividend safety score for Dianthus Therapeutics Inc. stock2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Dianthus Therapeutics (NASDAQ:DNTH) Sets New 1-Year HighWhat's Next? - MarketBeat
Will Dianthus Therapeutics Inc. (87E) stock hit Wall Street targetsWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
Can Dianthus Therapeutics Inc. stock hit analyst price targetsEarnings Overview Summary & AI Powered Buy/Sell Recommendations - newser.com
Dianthus Therapeutics Stock (DNTH) Opinions on Recent Price Surge and Clinical Trial Results - Quiver Quantitative
Is Dianthus Therapeutics Inc. (87E) stock a fit for income portfoliosNew Guidance & Safe Entry Point Identification - newser.com
What recovery options are there for Dianthus Therapeutics Inc.July 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 6.7%Here's What Happened - MarketBeat
Dianthus therapeutics EVP Randhawa sells $7.3m in shares By Investing.com - Investing.com Nigeria
Wellington Management Group LLP's Strategic Acquisition in Diant - GuruFocus
Dianthus therapeutics EVP Randhawa sells $7.3m in shares - Investing.com
Dianthus Therapeutics EVP Sells Shares Worth Over $7 Million - TradingView
VP Randhawa Sells 196,538 ($7.4M) Of Dianthus Therapeutics Inc [DNTH] - TradingView
Dianthus Therapeutics stock hits 52-week high at 40.4 USD By Investing.com - Investing.com Nigeria
Aug Analyst Calls: Is Dianthus Therapeutics Inc. (87E) stock resilient in recession scenariosIPO Watch & Weekly Breakout Watchlists - Fundação Cultural do Pará
Will Dianthus Therapeutics Inc. (87E) stock outperform value peers2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
What to expect from Dianthus Therapeutics Inc. in the next 30 days2025 Trading Volume Trends & Community Trade Idea Sharing - newser.com
Will Dianthus Therapeutics Inc. stock see PE expansionJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
Dianthus Therapeutics Inc (DNTH) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):